Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 3 » Issue 6

Sleep disturbances and suicide risk: A review of the literature

Authors Rebecca A Bernert, Thomas E Joiner

Published 15 January 2008 Volume 2007:3(6) Pages 735—743

DOI http://dx.doi.org/10.2147/NDT.S1248

Rebecca A Bernert, Thomas E Joiner

Department of Psychology, Florida State University, Tallahassee, FL, USA

Abstract: A growing body of research indicates that sleep disturbances are associated with suicidal ideation and behaviors. This article (1) provides a critical review of the extant literature on sleep and suicidality and (2) addresses shared underlying neurobiological factors, biological and social zeitgebers, treatment implications, and future directions for research. Findings indicate that suicidal ideation and behaviors are closely associated with sleep complaints, and in some cases, this association exists above and beyond depression. Several cross-sectional investigations indicate a unique association between nightmares and suicidal ideation, whereas the relationship between insomnia and suicidality requires further study. Underlying neurobiological factors may, in part, account for the relationship between sleep and suicide. Serotonergic neurotransmission appears to play a critical role in both sleep and suicide. Finally, it remains unclear whether or not sleep-oriented interventions may reduce risk for suicidal behaviors. Unlike other suicide risk factors, sleep complaints may be particularly amenable to treatment. As a warning sign, disturbances in sleep may thus be especially useful to research and may serve as an important clinical target for future suicide intervention efforts.

Keywords: suicidality, sleep, nightmares, suicide risk factors

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions

Sun DQ, Wei XB, Xue X, Fang ZJ, Ren MR, Lou HY, Zhang XM

International Journal of Nanomedicine 2014, 9:3413-3423

Published Date: 18 July 2014

Clinical diaries in COPD: compliance and utility in predicting acute exacerbations

Walters EH, Walters J, Wills KE, Robinson A, Wood-Baker R

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:427-435

Published Date: 10 July 2012

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis

Oghenowede Eyawo, Jean Nachega, Pierre Lefebvre, et al

Clinical Ophthalmology 2009, 3:447-456

Published Date: 31 July 2009

Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease

Felix C Ringshausen, Ai-Yui M Tan, Tobias Allander, Irmgard Borg, Umut Arinir, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:111-117

Published Date: 4 February 2009

Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples

Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, et al

Vascular Health and Risk Management 2009, 5:45-52

Published Date: 7 December 2008

Did depressive symptoms affect recognition of emotional prosody in Parkinson’s disease?

Adriana Vélez Feijó, Carlos RM Rieder, Márcia LF Chaves

Neuropsychiatric Disease and Treatment 2008, 4:669-674

Published Date: 6 June 2008